Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SEEL

Seelos Therapeutics (SEEL) Stock Price, News & Analysis

Seelos Therapeutics logo

About Seelos Therapeutics Stock (NASDAQ:SEEL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2 shs
Average Volume
174,745 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SEEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SEEL Stock News Headlines

Seelos Therapeutics Stock Price History
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Seelos Therapeutics, Inc. (SEELQ)
Seelos Therapeutics Inc SEELQ
See More Headlines

SEEL Stock Analysis - Frequently Asked Questions

Shares of Seelos Therapeutics reverse split on Friday, September 27th 2024.The 1-16 reverse split was announced on Wednesday, September 25th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Seelos Therapeutics investors own include Digital Turbine (APPS), Okta (OKTA), CrowdStrike (CRWD), SoFi Technologies (SOFI) and ChargePoint (CHPT).

Company Calendar

Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SEEL
CIK
1017491
Employees
20
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.88 million
Net Margins
203.13%
Pretax Margin
203.13%
Return on Equity
N/A
Return on Assets
-431.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.08
Quick Ratio
0.08

Sales & Book Value

Annual Sales
$2.20 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($437.92) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
372,000
Free Float
368,000
Market Cap
N/A
Optionable
Optionable
Beta
1.94

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SEEL) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners